The North America Spine Bone Stimulators Market is expected to witness market growth of 3.7% CAGR during the forecast period (2022-2028).
A bone growth stimulator (BGS) helps the bone mend faster by sending more power to the healing bone surface via pulsed electromagnetic or ultrasonic waves. Only external bone growth stimulators are used by the Orthopedic doctors at OSC. Internal BGS units are costly, require a second operation to remove the unit's battery and wires from the body, and are implanted at the moment of surgery.
External BGS can be used on practically any part of the body if there has been a fracture or surgery. They come in two forms devices that link to electrodes that supply electricity to the skin over the non-healing bone and braces or belts that can be worn or used to recline a patient when sitting. To be effective, the BGS device must be used for multiple hours each day for three to nine months, and patients’ satisfaction is needed to attain the greatest results. The units are lightweight, comfy, and secure. Unlike TENs units, they do not require any modifications. The electric current is imperceptible to the patient and produces no discomfort.
The rise in spine surgery usage in the United States has been very well reported. Technological developments, elderly patients anticipating greater levels of function, and funding mechanisms that favor advanced fusion surgery have all assisted the growth of the spine bone stimulator market in the United States. According to the 2019 SCI Datasheet from the National Spinal Cord Injury Statistical Center, the annual incidence of spinal cord injury (SCI) in the United States is roughly 54 cases per one million people, or around 17,810 new SCI-related cases each year. There were millions of people with spinal cord injuries in the United States in 2019.
Furthermore, according to the American Chiropractic Association, nearly 31 million people in the United States suffer from lower back pain at some point in their lives in 2018. Obesity, an inactive lifestyle, athletics, and accident-related ailments all contribute to the rise in spinal non-fusion treatments. Furthermore, posterior operations have gained in popularity in recent years and are expected to expand faster in the future than anterior treatments. As a result, as the number of treatments performed in the country grows, so does the number of spine bone stimulators utilize.
The US market dominated the North America Spine Bone Stimulators Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $170.1 million by 2028. The Canada market is anticipated to grow at a CAGR of 6% during (2022 - 2028). Additionally, The Mexico market is expected to display a CAGR of 5.1% during (2022 - 2028).
Based on Device Type, the market is segmented into Non-Invasive and Invasive. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DJO Global, Inc. (Enovis), Zimmer Biomet, Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, IGEA S.p.A., ManaMed Inc., Theragen, Inc., Intelligent Implants, and Orchid Medical, Inc
A bone growth stimulator (BGS) helps the bone mend faster by sending more power to the healing bone surface via pulsed electromagnetic or ultrasonic waves. Only external bone growth stimulators are used by the Orthopedic doctors at OSC. Internal BGS units are costly, require a second operation to remove the unit's battery and wires from the body, and are implanted at the moment of surgery.
External BGS can be used on practically any part of the body if there has been a fracture or surgery. They come in two forms devices that link to electrodes that supply electricity to the skin over the non-healing bone and braces or belts that can be worn or used to recline a patient when sitting. To be effective, the BGS device must be used for multiple hours each day for three to nine months, and patients’ satisfaction is needed to attain the greatest results. The units are lightweight, comfy, and secure. Unlike TENs units, they do not require any modifications. The electric current is imperceptible to the patient and produces no discomfort.
The rise in spine surgery usage in the United States has been very well reported. Technological developments, elderly patients anticipating greater levels of function, and funding mechanisms that favor advanced fusion surgery have all assisted the growth of the spine bone stimulator market in the United States. According to the 2019 SCI Datasheet from the National Spinal Cord Injury Statistical Center, the annual incidence of spinal cord injury (SCI) in the United States is roughly 54 cases per one million people, or around 17,810 new SCI-related cases each year. There were millions of people with spinal cord injuries in the United States in 2019.
Furthermore, according to the American Chiropractic Association, nearly 31 million people in the United States suffer from lower back pain at some point in their lives in 2018. Obesity, an inactive lifestyle, athletics, and accident-related ailments all contribute to the rise in spinal non-fusion treatments. Furthermore, posterior operations have gained in popularity in recent years and are expected to expand faster in the future than anterior treatments. As a result, as the number of treatments performed in the country grows, so does the number of spine bone stimulators utilize.
The US market dominated the North America Spine Bone Stimulators Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $170.1 million by 2028. The Canada market is anticipated to grow at a CAGR of 6% during (2022 - 2028). Additionally, The Mexico market is expected to display a CAGR of 5.1% during (2022 - 2028).
Based on Device Type, the market is segmented into Non-Invasive and Invasive. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DJO Global, Inc. (Enovis), Zimmer Biomet, Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, IGEA S.p.A., ManaMed Inc., Theragen, Inc., Intelligent Implants, and Orchid Medical, Inc
Scope of the Study
Market Segments Covered in the Report:
By Device Type
- Non-Invasive
- Invasive
By End User
- Hospitals
- Specialty Clinics
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- DJO Global, Inc. (Enovis)
- Zimmer Biomet
- Orthofix Medical Inc.
- Elizur Corporation
- Ossatec Benelux BV
- IGEA S.p.A.
- ManaMed Inc.
- Theragen, Inc.
- Intelligent Implants
- Orchid Medical, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Spine Bone Stimulators Market by Device Type
Chapter 5. North America Spine Bone Stimulators Market by End User
Chapter 6. North America Spine Bone Stimulators Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- DJO Global, Inc. (Enovis)
- Zimmer Biomet
- Orthofix Medical Inc.
- Elizur Corporation
- Ossatec Benelux BV
- IGEA S.p.A.
- ManaMed Inc.
- Theragen, Inc.
- Intelligent Implants
- Orchid Medical, Inc.
Methodology
LOADING...
